| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EPB42 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-10 |
| mRNA | MS4A2 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-09 |
| mRNA | CA1 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-08 |
| mRNA | C10orf128 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | OSM | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | MS4A6A | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | FCER1A | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | ALAS2 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | CD4 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | TBATA | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-07 |
